Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents

Abstract

The incidence of IgD myeloma is 2.5%. Although patients with IgD myeloma present more often with high-risk features, their outcome in the era of novel agents is similar to that of patients with other myeloma subtypes.